pyrroles has been researched along with Depression, Involutional in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jha, MK | 1 |
| de Boer, P; Drevets, W; Jacobs, G; Kent, J; Luthringer, R; Recourt, K; van der Ark, P; van Gerven, J; Van Hove, I; van Nueten, L; Zuiker, R | 1 |
| Drevets, WC; Etropolski, M; Savitz, A; Thase, ME; Wajs, E; Xu, H; Zhang, Y | 1 |
| Brooks, S; de Boer, P; Drevets, W; Jacobs, GE; Kent, JM; Kezic, I; Luthringer, R; van Amerongen, G; van der Ark, P; van Gerven, JM; Van Nueten, L; Zuiker, R | 1 |
| Ahmadpanah, M; Bajoghli, H; Brand, S; Haghighi, M; Holsboer-Trachsler, E; Jahangard, L; Khodakarami, S | 1 |
| Berk, M; Henry, MJ; Jacka, FN; Kotowicz, MA; Nicholson, GC; Pasco, JA; Williams, LJ | 1 |
4 trial(s) available for pyrroles and Depression, Involutional
| Article | Year |
|---|---|
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Arousal; Depressive Disorder, Major; Diphenhydramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pyrimidines; Pyrroles; Sleep; Treatment Outcome; Triazoles | 2019 |
Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pyrimidines; Pyrroles; Treatment Outcome; Triazoles | 2021 |
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.
Topics: Adult; Aged; Antidepressive Agents; Cross-Over Studies; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Orexin Receptor Antagonists; Polysomnography; Pyrimidines; Pyrroles; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Young Adult | 2019 |
In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder.
Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Atorvastatin; Chi-Square Distribution; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Heptanoic Acids; Humans; Lipids; Male; Psychiatric Status Rating Scales; Pyrroles; Treatment Outcome; Young Adult | 2014 |
2 other study(ies) available for pyrroles and Depression, Involutional
| Article | Year |
|---|---|
Selective Orexin Receptor Antagonists as Novel Augmentation Treatments for Major Depressive Disorder: Evidence for Safety and Efficacy From a Phase 2B Study of Seltorexant.
Topics: Adult; Depressive Disorder, Major; Humans; Orexin Receptor Antagonists; Pyrimidines; Pyrroles; Triazoles | 2022 |
Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression.
Topics: Aspirin; Atorvastatin; Case-Control Studies; Confidence Intervals; Cytokines; Depressive Disorder, Major; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Middle Aged; Models, Psychological; Pravastatin; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Time Factors | 2010 |